#ACTT1

Updated the #RECOVERYtrial topline results summary table of the #dexamethasone arm compared to usual care for treatment of hospitalized patients with #COVID19.Got additional information colleagues shared in Twitter.Thread with some
Read more
It took a while to digest the details of over 600 pages, but here is my review and comparative analysis of the #ACTT2 trial that compared #baricitinib vs. #placebo among
Read more
Time to share some thoughts and questions following the .@medrxivpreprint first release of results from the #SolidarityTrial that compared local standard care to #remdesivir, #HydroxyChloroquine #lopinavir_ritonavir and #interferon for trea
Read more
With the .@NIAIDNews #ACCT1 trial final report published on 05 Nov 2020 and the .@WHO's #SolidarityTrial Preliminary report published on 02 December 2020, thought it would be good to take
Read more
DGCI clears Biocon's anti-CD-6 inhibitor for Moderate to Severe COVID Patients for Restricted Emergency Use.https://www.news18.com/news/india/dcgi-approves-psoriasis-injection-itolizumab-for-restricted-emergency-use-to-treat-covid-19-pa
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.